1. Predicting Survival in Colorectal Liver Metastasis: Time for New Approaches

   • Georgios Antonios Margonis
   • Nikolaos Andreatos
   • Murray F. Brennan

   Hepatobiliary Tumors 31 August 2020 Pages: 4861 - 4863

2. The Interplay of Primary Tumor Location and KRAS Mutation Status in Patients with Synchronous Colorectal Cancer Liver Metastases: Current Data and Unanswered Questions

   • Georgios Antonios Margonis
   • Nikolaos Andreatos
   • Michael D’Angelica

   Hepatobiliary Tumors 21 September 2020 Pages: 4864 - 4866

3. Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation

   • Rebecca M. Shulman
   • Joshua E. Meyer

   Hepatobiliary Tumors 17 August 2020 Pages: 4867 - 4869

4. Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes

   • Georgia M. Beasley

   Melanoma 10 September 2020 Pages: 4870 - 4871

5. Editorial on “Simultaneous Ipsilateral Vascularized Lymph Node Transplantation and Contralateral Lymphovenous Anastomosis in Bilateral Different-Severities Extremity Lymphedema”

   • Mark V. Schaverien

   Reconstructive Oncology 25 June 2020 Pages: 4872 - 4873

6. Dextrose-Containing Carrier Solution for Hyperthermic Intraperitoneal Chemotherapy: Increased Intraoperative Hyperglycemia and Postoperative Complications

   • Robert J. Torphy
   • Camille Stewart
   • Steven A. Ahrendt

   Peritoneal Surface Malignancy 19 April 2020 Pages: 4874 - 4882

   

7. Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study

   • Benjamin D. Powers
   • Seth Felder
   • Sean P. Dineen

   Peritoneal Surface Malignancy 21 April 2020 Pages: 4883 - 4891

   

8. ASO Author Reflections: To Redo or Not to Redo, That is the Question: Assessing the Slings and Arrows of Repeat CRS/HIPEC in Patients with Recurrent or Progressive Peritoneal Carcinomatosis

   • Benjamin D. Powers
   • Sean P. Dineen

   ASO Author Reflections 21 April 2020 Pages: 4892 - 4893

9. The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC

   • Michael K. Turgeon
   • Adriana C. Gamboa
   • Joshua H. Winer

   Peritoneal Surface Malignancy 06 May 2020 Pages: 4894 - 4907

   

10. Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Andrei Nikiforchin
    • Mary Caitlin King
    • Armando Sardi

    Peritoneal Surface Malignancy 14 May 2020 Pages: 4908 - 4917

    

11. ASO Author Reflections: Not All Low-Grade Appendiceal Mucinous Neoplasm Mucin is Created Equal

    • Andrei Nikiforchin
    • Vadim Gushchin
    • Armando Sardi

    ASO Author Reflections 20 May 2020 Pages: 4918 - 4919

12. What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?

    • Patrick B. Schwartz
    • Christopher C. Stahl
    • Daniel E. Abbott

    Peritoneal Surface Malignancy 15 May 2020 Pages: 4920 - 4928

    

13. ASO Author Reflections: Predictors of Fiscal Outcomes in CRS-HIPEC and Opportunities for Improvement

    • Patrick B. Schwartz
    • Daniel E. Abbott

    ASO Author Reflections 16 May 2020 Pages: 4929 - 4930

14. Pelvic Anastomosis Without Protective Ileostomy is Safe in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Ekaterina Baron
    • Vadim Gushchin
    • Armando Sardi

    Peritoneal Surface Malignancy 06 June 2020 Pages: 4931 - 4940

    

15. ASO Author Reflections: Is CRS/HIPEC an Indication to Divert Rectal Anastomosis?

    • Ekaterina Baron
    • Vadim Gushchin
    • Armando Sardi

    ASO Author Reflections 27 May 2020 Pages: 4941 - 4942

16. Rate of Peritoneal Carcinomatosis in Resected Stage II and III Colon Cancer

    • Audrey H. Choi
    • Cyrus Farzaneh
    • Maheswari Senthil

    Peritoneal Surface Malignancy 14 June 2020 Pages: 4943 - 4948

17. ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters

    • Audrey H. Choi
    • Maheswari Senthil

    ASO Author Reflections 06 July 2020 Pages: 4949 - 4949

18. Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform

    • Steven D. Forsythe
    • Shyama Sasikumar
    • Konstantinos I. Votanopoulos

    Peritoneal Surface Malignancy 06 July 2020 Pages: 4950 - 4960

    

19. ASO Author Reflections: Patient-Derived Tumor Organoids—A Platform for a Precision Approach for Peritoneal Malignancies

    • Steven D. Forsythe
    • Omeed Moaven
    • Konstantinos I. Votanopoulos

    ASO Author Reflections 27 July 2020 Pages: 4961 - 4962

20. Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis

    • Michael G. White
    • Anai Kothari
    • Brian Badgwell

    Peritoneal Surface Malignancy 09 July 2020 Pages: 4963 - 4969

    

21. Robotic Major Hepatectomy: An Institutional Experience and Clinical Outcomes

    • Iswanto Sucandy
    • Kenneth Luberice
    • Alexander Rosemurgy

    Peritoneal Surface Malignancy 13 July 2020 Pages: 4970 - 4979

    

22. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative

    • Adriana C. Gamboa
    • Rachel M. Lee
    • Charles A. Staley

    Peritoneal Surface Malignancy 21 July 2020 Pages: 4980 - 4995

    

23. CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative

    • David Roife
    • Benjamin D. Powers
    • Sean P. Dineen

    Peritoneal Surface Malignancy 18 October 2020 Pages: 4996 - 5004

    

24. Cellular Immunoprofile of Peritoneal Environment During a HIPEC Procedure

    • Jan Franko
    • Rushin Brahmbhatt
    • Matthew Andres

    Peritoneal Surface Malignancy 21 July 2020 Pages: 5005 - 5013

    

25. ASO Author Reflections: Characterizing the Peritoneal Immune Response to the Surgical and Thermal Trauma of Peritoneal Cytoreduction and HIPEC

    • Jan Franko
    • Benjamin Ferrel
    • Marc Gorvet

    ASO Author Reflections 27 July 2020 Pages: 5014 - 5015

26. Clinical Implications of Genetic Signatures in Appendiceal Cancer Patients with Incomplete Cytoreduction/HIPEC

    • Omeed Moaven
    • Jing Su
    • Lance D. Miller

    Peritoneal Surface Malignancy 23 July 2020 Pages: 5016 - 5023

    

27. ASO Author Reflections: Molecular Profiling Can Provide Personalized Clinical Guidance in the Management of Peritoneal Malignancies

    • Omeed Moaven
    • Lance D. Miller
    • Edward A. Levine

    ASO Author Reflections 04 August 2020 Pages: 5024 - 5025

28. Defining “Complete Cytoreduction” After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis

    • Carlos A. Munoz-Zuluaga
    • Mary C. King
    • Armando Sardi

    Peritoneal Surface Malignancy 23 July 2020 Pages: 5026 - 5036

    

29. ASO Author Reflections: Time to Change: Redefining “Complete Cytoreduction” in Appendiceal Carcinomatosis

    • Carlos Munoz-Zuluaga
    • Mary Caitlin King
    • Armando Sardi

    ASO Author Reflections 15 September 2020 Pages: 5037 - 5038

30. Benchmarking Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement

    • Jason B. Liu
    • Darryl Schuitevoerder
    • Oliver S. Eng

    Peritoneal Surface Malignancy 29 July 2020 Pages: 5039 - 5046

    

31. Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma

    • Alisa N. Blumenthaler
    • Casey J. Allen
    • Brian D. Badgwell

    Peritoneal Surface Malignancy 31 July 2020 Pages: 5047 - 5056

    

32. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from Gastric Cancer

    • Hideyuki Ohzawa
    • Yuki Kimura
    • Joji Kitayama

    Peritoneal Surface Malignancy 17 August 2020 Pages: 5057 - 5064

    

33. Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies

    • Katie M. Leick
    • Austin G. Kazarian
    • Carlos H. F. Chan

    Translational Research 09 July 2020 Pages: 5065 - 5071

    

34. ASO Author Reflections: Potential Values of Peritoneal Cell-Free Tumor DNA Testing

    • Carlos H. F. Chan

    ASO Author Reflections 19 October 2020 Pages: 5072 - 5073

35. Metastatic Colorectal Cancers with Mismatch Repair Deficiency Result in Worse Survival Regardless of Peritoneal Metastases

    • Scott K. Sherman
    • Darryl Schuitevoerder
    • Kiran K. Turaga

    Colorectal Cancer 24 June 2020 Pages: 5074 - 5083

    

36. ASO Author Reflections: Mismatch Repair and Survival in Metastatic Colorectal Cancer

    • Scott K. Sherman
    • Carlos H. F. Chan

    ASO Author Reflections 06 July 2020 Pages: 5084 - 5085

37. Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases

    • John M. Creasy
    • Kyle J. Napier
    • Michael E. Lidsky

    Colorectal Cancer 10 August 2020 Pages: 5086 - 5095

    

38. ASO Author Reflections: Implementation of a New Hepatic Artery Infusion Program for Colorectal Liver Metastases is Safe, Feasible, and Effective

    • John M. Creasy
    • Michael E. Lidsky

    ASO Author Reflections 19 August 2020 Pages: 5096 - 5097

39. Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement

    • Brian C. Brajcich
    • David J. Bentrem
    • Ryan P. Merkow

    Hepatobiliary Tumors 01 August 2020 Pages: 5098 - 5106

40. Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia

    • Michael J. Carr
    • James Sun
    • Jonathan S. Zager

    Melanoma 11 September 2020 Pages: 5107 - 5118

    

41. ASO Author Reflections: Return to Isolated Limb Infusion for In-Transit Melanoma

    • Michael J. Carr
    • Hidde M. Kroon
    • Jonathan S. Zager

    ASO Author Reflections 11 September 2020 Pages: 5119 - 5120

42. Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy

    • Norma E. Farrow
    • Vignesh Raman
    • Georgia M. Beasley

    Melanoma 20 April 2020 Pages: 5121 - 5125

    

43. ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy

    • Norma E. Farrow
    • Georgia M. Beasley

    ASO Author Reflections 14 May 2020 Pages: 5126 - 5127

44. Adjuvant Therapy Failure Patterns in the Modern Era of Melanoma Management

    • Daan Jan Willem Rauwerdink
    • George Molina
    • Genevieve Marie Boland

    Melanoma 23 May 2020 Pages: 5128 - 5136

    

45. ASO Author Reflections: Adjuvant Treatment of Melanoma in the Modern Era

    • Daan Jan Willem Rauwerdink
    • Genevieve Marie Boland

    ASO Author Reflections 28 May 2020 Pages: 5137 - 5138

46. A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases

    • Anghela Z. Paredes
    • J. Madison Hyer
    • Timothy M. Pawlik

    Hepatobiliary Tumors 10 August 2020 Pages: 5139 - 5147

    

47. ASO Author Reflections: Development and Validation of a Novel Risk Score Using Machine-Learning Methodology to Predict Recurrence After Hepatectomy for Colorectal Liver Metastases

    • Anghela Z. Paredes
    • Diamantis I. Tsilimigras
    • Timothy M. Pawlik

    ASO Author Reflections 09 August 2020 Pages: 5148 - 5149

48. Prognosis of Synchronous Colorectal Liver Metastases After Simultaneous Curative-Intent Surgery According to Primary Tumor Location and KRAS Mutational Status

    • Ho Seung Kim
    • Jong Min Lee
    • Nam Kyu Kim

    Hepatobiliary Tumors 18 August 2020 Pages: 5150 - 5158

    

49. ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases

    • Ho Seung Kim
    • Nam Kyu Kim

    ASO Author Reflections 19 August 2020 Pages: 5159 - 5160

50. Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation

    • Edward Christopher Dee
    • Morgan E. Freret
    • Jennifer Y. Wo

    Hepatobiliary Tumors 01 August 2020 Pages: 5161 - 5172